2 ms·
Two points. Might be easy to miss, but I think the equally (if not more) concerning result of this study is that "Results were posted for 103 studies (25%) and
by icegreentea2 3y ago
Two points.
Might be easy to miss, but I think the equally (if not more) concerning result of this study is that "Results were posted for 103 studies (25%) and, in 24 (6%) studies, results were first posted within 6 months after approval.". Now, clearly the FDA has the unposted results to make their decision, but I do agree that it's incredibly concerning that these results are being posted promptly.
Second... ugh, I wish they just published their scraped dataset along with this letter. It's only a 413 row spreadsheet. Come on. I know there's a note saying "How to access data: We will provide access to the data on a Stanford University website"... but come onnnnn (I went poking a tiny bit, I couldn't find it yet)